2024-05-31T12:39:20-04:00 2023-09-30 461041593 FINANCIAL SOLUTION ADVISORS PLLC 4350 PABLO PROFESSIONAL CT STE 200 JACKSONVILLE FL 322243224 990 2022-10-01 561655431 INSTITUTE FOR MEDICAL RESEARCH INC INST 9192507013 508 FULTON ST 151/IMR DURHAM NC 27705 MICHELE PACKARD-MILAM INT EXEC DIR 2024-05-31 true MICHELE PACKARD-MILAM 999009999 false MICHAEL B MCLEOD CPA P00966646 9042962024 2024-05-31 2022 2023-04-26 12:10:37Z MICHELE PACKARD-MILAM 508 FULTON ST 151/IMR DURHAM NC 27705 23354518 false X IMR.ORG X 1989 NC TO SUPPORT RESEARCH AND EDUCATION THROUGHOUT THE DURHAM VETERANS AFFAIRS HEALTH CARE SYSTEM. 7 3 155 0 5071 0 7856185 20502761 9819 113852 5272 140063 7876347 20756676 0 0 5103682 11127010 0 0 4844190 4639240 9947872 15766250 -2071525 4990426 5835101 13072926 2384414 4636548 3450687 8436378 X THE PURPOSE OF THE INSTITUTE OF MEDICAL RESEARCH, INC. IS TO SUPPORT RESEARCH AND EDUCATION THROUGHOUT THE DURHAM VETERANS AFFAIRS HEALTHCARE SYSTEM TO ENHANCE THE HEALTH AND LIVES OF VETERANS, THEIR FAMILIES AND THE PUBLIC AT LARGE. false false 14082272 20502761 SUPPORTED A MEDICAL TRAINING AND EDUCATION PROGRAM TO SUPPORT THE VA PHARMACOGENOMICS ACTION FOR CANCER SURVIVORSHIP (PHASER). EXPANDED ACCESS TO PHARMACOGENOMIC (PGX) TESTING, INCLUDING PROVIDING BASIC PGX EDUCATION, TO AN ADDITIONAL 10,000 VETERANS SEEN ACROSS 25 VA HEALTH CARE SYSTEMS NATIONWIDE. ENGAGED IN PHARMACOGENOMIC EDUCATION WITH APPROXIMATELY 1,000 NEW VA PROVIDERS IN ADDITION TO HOSTING MONTHLY PGX BROWN BAG LEARNING SESSIONS AND RELEASING A MONTHLY PGX NEWSLETTER TO OVER 1,700 CLINICIANS. SECURED COMMITMENTS FROM ANOTHER 27 VA HOSPITALS TO IMPLEMENT THE PHASER PGX TESTING PROGRAM. BUILT AND RELEASED NATIONALLY AUTOMATED CLINICAL DECISION SUPPORT TOOLS FOR DRUG-GENE ALERTS FOR ALL STATINS AND SELECT SSRIS, NSAIDS, PPIS, CLOPIDOGREL, ONDANSETRON, AND LOOK TO HAVE RELEASED BEFORE THE END OF THE CALENDAR YEAR ALERTS TO SUPPORT DRUG-GENE ALERTS FOR SELECT TCAS, ATOMOXETINE, PHENYTOIN, TACROLIMUS, TAMOXIFEN, AND VORICONAZOLE. PREPARED THE EDUCATION AND TECHNICAL ENVIRONMENTS FOR A TESTING PANEL EXPANSION FROM 11 TO 15 GENES DUE TO BE RELEASED BY THE END OF THE CALENDAR YEAR. SUPPORTED NUMEROUS PROJECTS TO FURTHER AID WITH THE DIAGNOSIS, RISK STRATIFICATION AND LIFE STYLE INTERVENTION FOR THE BENEFIT OF UROLOGY AND ONCOLOGY PATIENTS. ACCOMODATED MAJOR GROWTH OF A PROSTATE CANCER PROGRAM TO ADD MULTIPLE PROJECTS, ADDING THOUSANDS OF PATIENTS AND NEW AVENUES OF PATIENT EDUCATION AND POTENTIAL TREATMENT. 14082272 true false false false false false false false false false false false false true true true true false false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 42 0 155 true false false false false false false false false false false false false false false X 7 3 false false false false false false false true true false false true true true true true true true false false X INSTITUTE FOR MEDICAL RESEARCH 9192507013 508 FULTON STREET 151/IMR DURHAM NC 27705 LIANA PUSCAS MD SECRETARY/TR 2.00 40.00 X X 0 395036 0 KENNETH GOLDBERG MD VICE PRESIDE 2.00 40.00 X X 0 337448 0 DAVID EDELMAN MD PRESIDENT 5.00 40.00 X X 0 244118 0 ALYSHIA SMITH DNP DIRECTOR 2.00 40.00 X 0 209300 0 JEFFREY SMITH FMR EX DIR 40.00 X 93956 0 0 RANKIN MCKENZIE LLC FRAC CFO 16.00 X 13020 0 0 MEGAN MADDEN CFO 40.00 X 9639 0 0 BRIAN LETOURNEAU DIRECTOR 2.00 X 5800 0 0 DENNIS SHIPMAN DIRECTOR 2.00 X 1000 0 0 PHIL LANDIS DIRECTOR 2.00 X 0 0 0 ROBERT ADAMS MD DIRECTOR 2.00 X 0 0 0 MICHELE PACKARD-MILAM INT EXEC DIR 40.00 X 0 0 0 123415 1185902 false true false NON-FEDERAL GRANTS 541700 17912888 17912888 FEDERAL GRANTS & CONTRACTS 541700 1959773 1959773 PERSONNEL AGREEMENTS 541700 630100 630100 20502761 113852 113852 2597842 2597842 EXPENSE RECOVERY & MISC 541700 140063 140063 140063 20756676 20756676 190195 190195 9173981 8517212 656769 118518 116930 1588 933922 708031 225891 710394 659236 51158 67622 19515 48107 24500 24500 1422747 1277486 145261 1062 1062 155843 66761 89082 135601 35146 100455 254556 162732 91824 90738 85390 5348 66866 64851 2015 22335 22335 INTER-INSTITUTIONAL AGREE 1525033 1525033 RESEARCH STUDY COSTS 774437 811037 -36600 BAD DEBT EXPENSE 83906 28312 55594 DUES & SUBSCRIPTIONS 13994 3538 10456 15766250 14082272 1683978 0 756360 1724240 2601759 1746984 2450640 6433373 12170 119747 1960000 14172 1088582 5835101 13072926 1565677 1260111 787959 2280985 30778 1095452 2384414 4636548 X 3318755 7169582 131932 1266796 3450687 8436378 5835101 13072926 4990426 -4735 X false true X true true true X DURHAM VETERAN AFFAIRS HEALTH CARE SYSTEM DURHAM NC OPERATING LEASE RIGHT OF USE, NET 1079059 SECURITY DEPOSITS 9523 1088582 OPERATING LEASE LIABILITIES, LNG TRM 850338 OPERATING LEASE LIABILITIES, CURRENT 245114 1095452 X 20751941 -4735 -4735 20756676 20756676 15766250 15766250 15766250 SCHEDULE D, PAGE 3, PART X THE ORGANIZATION FOLLOWS THE INCOME TAX STANDARD FOR UNCERTAIN TAX POSITIONS. THE ORGANIZATION HAS EVALUATED THEIR TAX POSITIONS AND DETERMINED THEY HAVE NO UNCERTAIN TAX POSITIONS AS OF SEPTEMBER 30, 2023 AND 2022. SHOULD THE ORGANIZATION'S TAX-EXEMPT STATUS BE CHALLENGED IN THE FUTURE, THE ORGANIZATION'S 2021, 2022 AND 2023 TAX YEARS ARE OPEN FOR EXAMINATION BY THE IRS. false false false false false false false false false LIANA PUSCAS MD SECRETARY/TREASURER 395036 395036 KENNETH GOLDBERG MD VICE PRESIDENT 337448 337448 DAVID EDELMAN MD PRESIDENT 244118 244118 ALYSHIA SMITH DNP DIRECTOR 209300 209300 FORM 990 - ORGANIZATION'S MISSION THE PURPOSE OF THE INSTITUTE OF MEDICAL RESEARCH, INC. IS TO SUPPORT RESEARCH AND EDUCATION THROUGHOUT THE DURHAM VETERANS AFFAIRS HEALTHCARE SYSTEM TO ENHANCE THE HEALTH AND LIVES OF VETERANS, THEIR FAMILIES AND THE PUBLIC AT LARGE. FORM 990, PAGE 2, PART III, LINE 4A SUPPORTED A MEDICAL TRAINING AND EDUCATION PROGRAM TO SUPPORT THE VA PHARMACOGENOMICS ACTION FOR CANCER SURVIVORSHIP (PHASER). EXPANDED ACCESS TO PHARMACOGENOMIC (PGX) TESTING, INCLUDING PROVIDING BASIC PGX EDUCATION, TO AN ADDITIONAL 10,000 VETERANS SEEN ACROSS 25 VA HEALTH CARE SYSTEMS NATIONWIDE. ENGAGED IN PHARMACOGENOMIC EDUCATION WITH APPROXIMATELY 1,000 NEW VA PROVIDERS IN ADDITION TO HOSTING MONTHLY PGX BROWN BAG LEARNING SESSIONS AND RELEASING A MONTHLY PGX NEWSLETTER TO OVER 1,700 CLINICIANS. SECURED COMMITMENTS FROM ANOTHER 27 VA HOSPITALS TO IMPLEMENT THE PHASER PGX TESTING PROGRAM. BUILT AND RELEASED NATIONALLY AUTOMATED CLINICAL DECISION SUPPORT TOOLS FOR DRUG-GENE ALERTS FOR ALL STATINS AND SELECT SSRIS, NSAIDS, PPIS, CLOPIDOGREL, ONDANSETRON, AND LOOK TO HAVE RELEASED BEFORE THE END OF THE CALENDAR YEAR ALERTS TO SUPPORT DRUG-GENE ALERTS FOR SELECT TCAS, ATOMOXETINE, PHENYTOIN, TACROLIMUS, TAMOXIFEN, AND VORICONAZOLE. PREPARED THE EDUCATION AND TECHNICAL ENVIRONMENTS FOR A TESTING PANEL EXPANSION FROM 11 TO 15 GENES DUE TO BE RELEASED BY THE END OF THE CALENDAR YEAR. FORM 990, PAGE 6, PART VI, LINE 11B THE FORM 990 IS REVIEWED IN DETAIL BY THE INSTITUTE'S FINANCIAL OFFICER, EXECUTIVE DIRECTOR, AND APPROPRIATE BOARD MEMBER WHO SUBSEQUENTLY RECOMMENDS APPROVAL AND FILING TO THE BOARD OF DIRECTORS. THE FORM 990 IS PROVIDED TO ALL BOARD MEMBERS PRIOR TO FILING. FORM 990, PAGE 6, PART VI, LINE 12C ALL NEW KEY EMPLOYEES AND BOARD MEMBERS ARE REQUIRED ANNUALLY TO COMPLETE A CONFLICT OF INTEREST TRAINING, WHICH SPECIFIES ACTION TO BE TAKEN IN THE EVENT OF A PERCEIVED CONFLICT OF INTEREST. FORM 990, PAGE 6, PART VI, LINE 15A THE EXECUTIVE DIRECTOR'S SALARY WAS REVIEWED NOVEMBER 2022. THE SALARY WAS DETERMINED BY COMPARATIVE VETERAN'S AFFAIRS NON-PROFITS' EXECUTIVE DIRECTORS' SALARIES AND FMV. SALARY WAS DETERMINED BY VOTE OF FULL BOARD OF DIRECTORS. FORM 990, PAGE 6, PART VI, LINE 19 THE GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. VETERANS AFFAIRS DEPARTMENT 508 FULTON ST DURHAM NC 27706 561932832 HEALTHCARE NC NA false false false false false false false false false false false false false false true false true false false false VETERANS AFFAIRS DEPARTMENT N INDETERMINABLE VETERANS AFFAIRS DEPARTMENT P 750000 CASH